Online citations, reference lists, and bibliographies.
← Back to Search

Macrophage Lipoprotein Lipase Promotes Foam Cell Formation And Atherosclerosis In Low Density Lipoprotein Receptor-deficient Mice*

V. Babaev, M. Patel, C. Semenkovich, S. Fazio, M. Linton
Published 2000 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The role of macrophage lipoprotein lipase (LPL) expression in atherosclerotic lesion formation was examined in low density lipoprotein receptor (LDLR−/−) mice using dietary conditions designed to induce either fatty streak lesions or complex atherosclerotic lesions. First, LDLR−/− mice chimeric for macrophage LPL expression were created by transplantation of lethally irradiated female LDLR−/− mice with LPL−/−(n = 12) or LPL+/+ (n = 14) fetal liver cells as a source of hematopoietic cells. To induce fatty streak lesions, these mice were fed a Western diet for 8 weeks, resulting in severe hypercholesterolemia. There were no differences in plasma post-heparin LPL activity, serum lipid levels, or lipoprotein distribution between these two groups. The mean lesion area in the proximal aorta in LPL−/− → LDLR−/−mice was significantly reduced by 33% compared with LPL+/+→ LDLR−/− mice, and a similar reduction (38%) in lesion area was found by en face analysis of the aortae. To induce complex atherosclerotic lesions, female LDLR−/−mice were lethally irradiated, transplanted with LPL−/−(n = 14), LPL+/− (n = 13), or LPL+/+ (n = 14) fetal liver cells, and fed the Western diet for 19 weeks. Serum cholesterol and triglyceride levels did not differ between the three groups. After 19 weeks of diet, the lesions in the proximal aorta were complex with relatively few macrophages expressing LPL protein and mRNA in LPL+/+ → LDLR−/− mice. Analysis of cross-sections of the proximal aorta demonstrated no differences in the extent of lesion area between the groups, whereas en faceanalysis of the aortae revealed a dose-dependent effect of macrophage LPL on mean aortic lesion area in LPL−/− → LDLR−/−, LPL−/+ → LDLR−/−, and LPL+/+ → LDLR−/− mice (1.8 ± 0.2%, 3.5 ± 0.5% and 5.9 ± 0.8%, respectively). Taken together, these data indicate that macrophage LPL expression in the artery wall promotes atherogenesis during foam cell lesion formation, but this impact may be limited to macrophage-rich lesions.
This paper references
The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages.
P. Lindqvist (1983)
10.1097/00041433-199404000-00008
Structure, function and role of lipoprotein lipase in lipoprotein metabolism.
S. Santamarina-Fojo (1994)
Modification of low density lipoprotein by lipoprotein lipase or hepatic lipase induces enhanced uptake and cholesterol accumulation in cells.
M. Aviram (1988)
10.1172/JCI115595
Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix.
U. Saxena (1992)
10.1073/PNAS.93.14.7242
Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase
M. Shimada (1996)
Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.
I. Tabas (1993)
Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma.
S. Whitman (1999)
10.1056/NEJM199901143400207
Atherosclerosis is an inflammatory disease.
R. Ross (1999)
10.1097/00041433-199510000-00009
Triglyceride lpases and atherosclerosis
G. Olivecrona (1995)
Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.
R. Tangirala (1995)
10.1097/00041433-199610000-00012
Macrophages and atherosclerotic plaque stability
P. Libby (1996)
Lipolysis-induced iron release from diferric transferrin: Possible role of lipoprotein lipase in LDL oxidation.
C. Balagopalakrishna (1999)
Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis.
I. Goldberg (1996)
10.1172/JCI6117
Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo.
V. Babaev (1999)
10.1073/PNAS.95.23.13841
Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo.
M. Merkel (1998)
10.1161/01.CIR.60.3.473
Atherogenesis: a postprandial phenomenon.
D. B. Zilversmit (1979)
10.1172/JCI116663
Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.
S. Ishibashi (1993)
Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
K. Williams (1992)
10.1073/PNAS.94.9.4647
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages.
S. Fazio (1997)
10.1016/0021-9150(85)90138-8
Variation in susceptibility to atherosclerosis among inbred strains of mice.
B. Paigen (1985)
10.1016/S0092-8674(00)81574-3
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
L. Nagy (1998)
Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size.
E. Zsigmond (1994)
10.1111/j.1365-3083.1987.tb02301.x
Macrophages in T and B Cell Compartments and Other Tissue Macrophages Recognized by Monoclonal Antibody MOMA‐2
G. Kraal (1987)
10.1172/JCI117915
Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
D. A. Purcell-Huynh (1995)
10.1073/PNAS.88.22.10143
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions.
S. Ylä-Herttuala (1991)
10.1172/JCI117179
Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.
S. Ishibashi (1994)
10.1073/PNAS.88.19.8342
Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein.
U. Beisiegel (1991)
10.1016/0006-291X(92)90267-O
Lipoprotein lipase-mediated lipolysis of very low density lipoproteins increases monocyte adhesion to aortic endothelial cells.
U. Saxena (1992)
10.1016/0021-9150(95)05792-7
New aspects on the role of plasma lipases in lipoprotein catabolism and atherosclerosis.
U. Beisiegel (1996)
10.1074/JBC.270.21.12518
COOH-terminal Disruption of Lipoprotein Lipase in Mice Is Lethal in Homozygotes, but Heterozygotes Have Elevated Triglycerides and Impaired Enzyme Activity (*)
T. Coleman (1995)
10.1006/BBRC.1998.9596
Mild oxidation of lipoproteins increases their affinity for surfaces covered by heparan sulfate and lipoprotein lipase.
E. Makoveichuk (1998)
10.1172/JCI116018
Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages.
S. Rumsey (1992)
Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase.
D. Chappell (1994)
Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL.
S. Whitman (1998)
10.1016/0021-9150(87)90202-4
Quantitative assessment of atherosclerotic lesions in mice.
B. Paigen (1987)
Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
M. Mulder (1993)
Identification and characterization of the endothelial cell surface lipoprotein lipase receptor.
U. Saxena (1991)
10.1172/JCI115747
Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.
K. O'brien (1992)
10.1016/S0092-8674(00)81575-5
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
P. Tontonoz (1998)



This paper is referenced by
10.1161/HQ1201.099426
Transforming Growth Factor-&bgr;1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants
C. Argmann (2001)
10.1016/J.COPH.2003.12.003
Cyclooxygenase-2 and inflammation in atherosclerosis.
M. Linton (2004)
10.1016/J.FERTNSTERT.2007.01.132
Estrogen increases apoptosis in the arterial wall in a murine atherosclerosis model.
E. Seli (2007)
10.1016/j.gene.2020.144364
Blood miR-1275 is associated with risk of ischemic stroke and inhibits macrophage foam cell formation by targeting ApoC2 gene.
Lu Li (2020)
10.1074/jbc.M110.159772
Adenosine Monophosphate-activated Protein Kinase Induces Cholesterol Efflux from Macrophage-derived Foam Cells and Alleviates Atherosclerosis in Apolipoprotein E-deficient Mice*
Dan Li (2010)
10.1074/jbc.M106774200
A Novel Role of Sp1 and Sp3 in the Interferon-γ-mediated Suppression of Macrophage Lipoprotein Lipase Gene Transcription*
T. Hughes (2002)
10.1016/j.atherosclerosis.2011.09.046
Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages.
Yasutaka Jinno (2011)
10.1177/0260106014563446
Effect of garlic powder tablet on carotid intima-media thickness in patients with coronary artery disease
M. Mahdavi-Roshan (2013)
10.1161/01.ATV.0000147163.54024.70
Molecular Interactions Leading to Lipoprotein Retention and the Initiation of Atherosclerosis
Maged F. Khalil (2004)
10.14670/HH-17.1317
Regulation of smooth muscle cell accumulation in diabetes-accelerated atherosclerosis.
B. Askari (2002)
10.1172/JCI29968
Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II.
M. Dahl (2007)
10.1161/CIRCULATIONAHA.112.000588
Targeting GGTase-I Activates RHOA, Increases Macrophage Reverse Cholesterol Transport, and Reduces Atherosclerosis in Mice
O. Khan (2013)
10.2741/1887
Antiatherogenic role of high-density lipoproteins: insights from genetically engineered-mice.
J. C. Escolà-Gil (2006)
10.1016/J.ATHEROSCLEROSIS.2005.08.032
Localized vessel expression of lipoprotein lipase in rabbits leads to rapid lipid deposition in the balloon-injured arterial wall.
Xiaojun Wu (2006)
Endogenous and exogenous factors affecting lipoprotein lipase activity
Mikael M Larsson (2014)
10.1161/CIRCRESAHA.115.306249
Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
B. Nordestgaard (2016)
10.1161/ATVBAHA.111.243519
Human ATP–Binding Cassette G1 Controls Macrophage Lipoprotein Lipase Bioavailability and Promotes Foam Cell Formation
M. Olivier (2012)
10.1128/MCB.22.8.2607-2619.2002
Conditional Disruption of the Peroxisome Proliferator-Activated Receptor γ Gene in Mice Results in Lowered Expression of ABCA1, ABCG1, and apoE in Macrophages and Reduced Cholesterol Efflux
T. Akiyama (2002)
10.1016/S0021-9150(02)00203-4
Peroxisome proliferator-activated receptor α and γ agonists upregulate human macrophage lipoprotein lipase expression
L. Li (2002)
10.3390/ijms13022219
Alpha7 Nicotinic Acetylcholine Receptor Is a Target in Pharmacology and Toxicology
Miroslav Pohanka (2012)
10.12997/jla.2020.9.2.231
Metabolic Reprogramming of Macrophages in Atherosclerosis: Is It All about Cholesterol?
L. Yvan-Charvet (2020)
10.1194/jlr.M600510-JLR200
Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages Published, JLR Papers in Press, July 20, 2007.
Guosong Qiu (2007)
10.1161/01.ATV.0000033090.81345.E6
Adipocyte Fatty Acid–Binding Protein, aP2, Alters Late Atherosclerotic Lesion Formation in Severe Hypercholesterolemia
J. Boord (2002)
10.1194/JLR.M400169-JLR200
Advanced glycation end products potentiate the stimulatory effect of glucose on macrophage lipoprotein lipase expression Published, JLR Papers in Press, June 21, 2004. DOI 10.1194/jlr.M400169-JLR200
M. Beauchamp (2004)
ATVB In Focus Lipoproteins, Inflammation, and Atherosclerosis
Mercedes Ricote (2004)
10.1194/JLR.M200108-JLR200
Physiological expression of macrophage apoE in the artery wall reduces atherosclerosis in severely hyperlipidemic mice DOI 10.1194/jlr.M200108-JLR200
S. Fazio (2002)
10.1210/ME.2003-0061
Liver X receptor signaling pathways in cardiovascular disease.
P. Tontonoz (2003)
10.1194/JLR.M500366-JLR200
Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE−/− and LDLR−/− mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional table. Published, JLR Papers in Press, September 30, 2005. DOI 10.1194/jlr.M500366-JLR200
K. W. Ko (2005)
10.1152/AJPENDO.00171.2007
Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
K. R. Coenen (2007)
10.1016/j.cmet.2010.01.003
A macrophage sterol-responsive network linked to atherogenesis.
L. Becker (2010)
10.1016/j.freeradbiomed.2010.10.702
Selective macrophage ascorbate deficiency suppresses early atherosclerosis.
V. Babaev (2011)
Features of the most commonly used mouse models of dyslipidemia and atherosclerosis
S. Fazio (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar